Join the Sumatriptan group to help and get support from people like you.
Sumatriptan News
Related terms: Sumatriptan Nasal
Migraine? Reach for Prescription Meds, Not Ibuprofen
THURSDAY, Nov. 30, 2023 – Migraine sufferers would do better to talk to their doctor about a prescription drug than reaching for a bottle of ibuprofen, a new study finds. Drugs like triptans, ergots...
FDA Approves Tosymra (sumatriptan) Nasal Spray for Acute Treatment of Migraine
January 27, 2019 – Dr. Reddy’s Laboratories Ltd. and its subsidiary, Promius Pharma, LLC today announced the approval of Tosymra (previously known as DFN-02) by the U.S. Food and Drug Administration ...
FDA Medwatch Alert: Zecuity (sumatriptan) Migraine Patch: Drug Safety Communication - FDA Evaluating Risk of Burns and Scars
ISSUE: FDA is investigating the risk of serious burns and potential permanent scarring with the use of Zecuity (sumatriptan iontophoretic transdermal system) patch for migraine headaches. Since...
FDA Approves Onzetra Xsail (sumatriptan nasal powder) for the Acute Treatment of Migraine
ALISO VIEJO, Calif., January 28, 2016 – Avanir Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Onzetra Xsail (sumatriptan nasal powder), formerly...
FDA Approves Treximet (sumatriptan and naproxen sodium) for Migraine in Pediatric Patients
MORRISTOWN, NJ – May 15, 2015 – Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved Tre...
NuPathe's Zecuity Approved by the FDA for the Acute Treatment of Migraine
CONSHOHOCKEN, PA--(Marketwire - Jan 17, 2013) - NuPathe Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Zecuity (sumatriptan iontophoretic transdermal system) for...
Ask a question
To post your own question to this support group, sign in or create an account.